BACKGROUND: Fibromyalgia syndrome (FMS) is a disease of unknown pathogenesis characterized by chronic musculoskeletal pain. FMS has been also associated with altered endocrinological responses, but findings are inconsistent. PURPOSE: The aim of the present study was to investigate free salivary cortisol levels in FMS patients compared with healthy controls with a particular focus on the cortisol awakening response (CAR). The saliva samples were collected in a controlled hospital-hotel setting, in which the participants' compliance was high and a number of potential confounders were analyzed. METHOD: Twenty-nine chronic female FMS patients and 29 age-matched healthy female controls were recruited. Salivary cortisol samples were investigated eight times: in the afternoon when participants arrived at the hospital, after stress provocation (to be reported separately), in the evening, before they went to sleep, upon awakening, 30 and 60 min later, and during the afternoon of the second day. Questionnaires measuring pain levels, sleeping problems, perceived stress, and personality were administered to the participants. Other psychophysiological measurements were used to assess sleep quality and heart rate. RESULTS: Patients with FMS had significantly lower cortisol levels during the day, most pronounced in the morning (CAR). The potential confounders analyzed did not influence the results. As expected, FMS patients reported more pain, stress, sleeping problems, anxiety, and depression. CONCLUSION: The results lend support to the hypothesis of a dysfunction in the hypothalamus-pituitary-adrenal axis in FMS patients, with generally lower cortisol values, most pronounced upon awakening (CAR).
BACKGROUND:Fibromyalgia syndrome (FMS) is a disease of unknown pathogenesis characterized by chronic musculoskeletal pain. FMS has been also associated with altered endocrinological responses, but findings are inconsistent. PURPOSE: The aim of the present study was to investigate free salivary cortisol levels in FMS patients compared with healthy controls with a particular focus on the cortisol awakening response (CAR). The saliva samples were collected in a controlled hospital-hotel setting, in which the participants' compliance was high and a number of potential confounders were analyzed. METHOD: Twenty-nine chronic female FMS patients and 29 age-matched healthy female controls were recruited. Salivary cortisol samples were investigated eight times: in the afternoon when participants arrived at the hospital, after stress provocation (to be reported separately), in the evening, before they went to sleep, upon awakening, 30 and 60 min later, and during the afternoon of the second day. Questionnaires measuring pain levels, sleeping problems, perceived stress, and personality were administered to the participants. Other psychophysiological measurements were used to assess sleep quality and heart rate. RESULTS:Patients with FMS had significantly lower cortisol levels during the day, most pronounced in the morning (CAR). The potential confounders analyzed did not influence the results. As expected, FMS patients reported more pain, stress, sleeping problems, anxiety, and depression. CONCLUSION: The results lend support to the hypothesis of a dysfunction in the hypothalamus-pituitary-adrenal axis in FMS patients, with generally lower cortisol values, most pronounced upon awakening (CAR).
Authors: Ilona Federenko; Stefan Wüst; Dirk H Hellhammer; Ralph Dechoux; Robert Kumsta; Clemens Kirschbaum Journal: Psychoneuroendocrinology Date: 2004-02 Impact factor: 4.905
Authors: Jennifer M Glass; Angela K Lyden; Frank Petzke; Phyllis Stein; Gail Whalen; Kirsten Ambrose; George Chrousos; Daniel J Clauw Journal: J Psychosom Res Date: 2004-10 Impact factor: 3.006
Authors: Jen D Wong; Marsha M Seltzer; Jan S Greenberg; Jinkuk Hong; David M Almeida; Christopher L Coe Journal: Aging Ment Health Date: 2012-05-29 Impact factor: 3.658
Authors: Robert R Edwards; Christine Cahalan; Christine Calahan; George Mensing; Michael Smith; Jennifer A Haythornthwaite Journal: Nat Rev Rheumatol Date: 2011-02-01 Impact factor: 20.543
Authors: José V Pardo; Robert C Larson; Rachel J Spencer; Joel T Lee; Jeffrey D Pasley; Carolyn J Torkelson; Alice A Larson Journal: Clin J Pain Date: 2019-05 Impact factor: 3.442
Authors: Kathryn M Godfrey; Eric Strachan; Elizabeth Dansie; Leslie J Crofford; Dedra Buchwald; Jack Goldberg; Brian Poeschla; Annemarie Succop; Carolyn Noonan; Niloofar Afari Journal: Ann Behav Med Date: 2014-04
Authors: Elizabeth Cash; Paul Salmon; Inka Weissbecker; Whitney N Rebholz; René Bayley-Veloso; Lauren A Zimmaro; Andrea Floyd; Eric Dedert; Sandra E Sephton Journal: Ann Behav Med Date: 2015-06